In-Room PET in Proton Radiation Therapy

Description

The investigational part of this study is using a mobile PET scanner called NeuroPET to take images of the participants tumor while they are receiving proton radiation treatment. This allows the participant to be treated and imaged in the same bed. The information obtained may improve the accuracy of treatment and may help to minimize the dose delivered unnecessarily to healthy tissue.

Study Start Date

October 2010

Estimated Completion Date

December 2016

Interventions

  • Procedure: PET scan

Specialties

  • Internal Medicine: Hematology/Oncology,Neurology,Radiology/Diagnostics
  • Neurology: Neurologic Oncology,Neuroradiology
  • Oncology: Head and Neck,Pharmacology/Therapy
  • Radiology: CT/SPECT/PET,Radiotherapy (XRT)

MeSH Terms

  • Brain Neoplasms
  • Head and Neck Neoplasms
  • PET scan
  • Skull Base Neoplasms

Study ID

Massachusetts General Hospital -- 10-241

Status

Unknown

Trial ID

NCT01228448

Study Type

Interventional

Trial Phase

Phase 0

Enrollment Quota

39

Sponsor

Massachusetts General Hospital

Inclusion Criteria

  • Adult subjects with brain, head and neck, and skull base tumors receiving external beam proton radiotherapy at the Francis H. Burr Proton Therapy Center at MGH
  • Age 18 or over
  • ECOG Performance status 0, 1 or 2
  • Subjects must have internal CT markers implanted on the skull as part of their radiation treatment planning

Exclusion Criteria

  • Uncontrolled intercurrent illness that, in the opinion of the investigator, would limit the participant's compliance with study requirements.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles None None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.